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ABSTRACT
Several RNA silencing pathways in plants restrict
viral infections and are suppressed by distinct viral
proteins. Here we show that the endogenous trans-
acting (ta)siRNA pathway, which depends on Dicer-
like (DCL) 4 and RNA-dependent RNA polymerase
(RDR) 6, is suppressed by infection of Arabidopsis
with Cauliflower mosaic virus (CaMV). This effect
was associated with overaccumulation of unproces-
sed, RDR6-dependent precursors of tasiRNAs and
is due solely to expression of the CaMV transactiva-
tor/viroplasmin (TAV) protein. TAV expression also
impaired secondary, but not primary, siRNA produc-
tion from a silenced transgene and increased accu-
mulation of mRNAs normally silenced by the four
known tasiRNA families and RDR6-dependent sec-
ondary siRNAs. Moreover, TAV expression upregu-
lated DCL4, DRB4 and AGO7 that mediate tasiRNA
biogenesis. Our findings suggest that TAV is a gen-
eral inhibitor of silencing amplification that impairs
DCL4-mediated processing of RDR6-dependent
double-stranded RNA to siRNAs. The resulting
deficiency in tasiRNAs and other RDR6-/DCL4-
dependent siRNAs appears to trigger a feedback
mechanism that compensates for the inhibitory
effects.
INTRODUCTION
Multiple RNA silencing pathways in plants downregulate
gene expression at transcriptional and post-transcriptional
levels by generating small (s)RNAs, 21–24 nt in length
(1–4). These sRNAs act either by guiding the cleavage of
cognate RNAs, blocking productive translation of these
RNAs, or inducing methylation of cognate DNA targets.
The major pathways in Arabidopsis diﬀer in the nature of
sRNA precursors and requirements for Dicer-like (DCL)
and RNA-dependent RNA polymerase (RDR) proteins.
Micro (mi)RNAs are generated by DCL1 from hairpin
structures of primary-miRNA transcripts. In contrast,
endogenous small interfering (si)RNAs are generated by
diﬀerent DCLs from double-stranded (ds)RNA precur-
sors produced by RDRs. For example, heterochromatic
and repeat-associated siRNAs are generated by DCL3
from RDR2-dependent precursors, whereas trans-acting
siRNAs (tasiRNAs) by DCL4 from RDR6-dependent
precursors. Both miRNAs and siRNAs bind Argonaute
(AGO) proteins and guide the resulting RNA-induced
silencing complexes (RISCs) to the complementary
region of target nucleic acids.
The present study focuses on eﬀects of viral infection on
the function and regulation of the tasiRNA-generating
(TAS) pathways. Genetic evidence and limited biochem-
ical data suggest that tasiRNA biogenesis is initiated by
miRNA-mediated cleavage of a primary TAS transcript to
generate a substrate for RDR6 that lacks the cap and/or
the poly(A) tail. The presumed long dsRNA product of
RDR6 activity is then processed by DCL4 from the
miRNA-cleaved terminus into 21-nt siRNA duplexes
with 2 nt 30-overhangs (Figure 1). TasiRNAs are encoded
by both strands of dsRNA precursors and at diﬀerent
in-phase positions, 2–12 21 nt processing cycles from the
site of miRNA cleavage (5–10).
Four Arabidopsis TAS families with up to three
distinct loci have been identiﬁed (6,9,11). TAS1 and
TAS2 tasiRNAs are initiated by miR173, TAS3 ones by
miR390 and TAS4 ones by miR828 (Figure 1). The TAS3
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family is special in that the two functional tasiRNAs are
encoded upstream of the miR390 cleavage site and that a
second miR390 target site further upstream is not cleaved
(12). The two miRNA target sites are thought to delimit
the region of TAS3 primary transcripts converted into
dsRNA. Although target mRNAs for all four TAS
families have been identiﬁed (9), biological functions
have only been elucidated for TAS3-tasiRNAs that
target the auxin-response factor genes ARF3 and ARF4
to control the juvenile-to-adult transition in leaf develop-
ment (13,14).
Recent evidence indicates that the AGO7 protein specif-
ically associates with miR390 to target the TAS3a tran-
script and thereby initiate tasiRNA biogenesis (15).
However, only the TAS3 pathway genetically requires
AGO7 (13) and the biogenesis of tasiRNAs of other
TAS families appear to be initiated by AGO1-RISC that
associates with most miRNAs (16,17). DRB4, a dsRNA
binding (DRB) protein, has been implicated in tasiRNA
biogenesis as a DCL4-binding partner (18). However,
DRB4-deﬁcient mutants still accumulate substantial
levels of 21 nt tasiRNAs from TAS1, TAS2 and TAS3
loci (13,19–21), suggesting that DCL4 does not absolutely
require DRB4 for processing dsRNA precursors of
tasiRNAs or that DRB4 acts downstream of the proces-
sing step.
Certain protein coding genes give rise to siRNAs that
depend on RDR6 for their production. Interestingly,
many of these genes are targets of tasiRNAs and, in
some cases, of miRNAs (9,12). A common feature of
such secondary siRNA-generating loci is that they are
targeted by more than one small RNA. It has been
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Figure 1. Models for the biogenesis of tasiRNAs from two distinct types of Arabidopsis tasiRNA-generating (TAS) loci. (A) For each type of
tasiRNA biogenesis the TAS gene structure is shown schematically with the promoter indicated with an arrow shape. Pol II transcription driven by
this promoter generates capped and polyadenylated transcript. This transcript is targeted for cleavage by miRNA. In the case of TAS1, TAS2 and
TAS4 tasiRNA families (top), the 30-product of this cleavage event is converted into dsRNAs by RDR6 activity. In the case of the TAS3 tasiRNA
family (bottom), the 50-product is converted into dsRNA by RDR6. In both cases, the resulting dsRNA is processed by DCL4 into 21-nt tasiRNAs.
Suppression of the latter step by the CaMV TAV protein is inferred from the present study.(B) The hypothetical dsRNAs derived from the
Arabidopsis Col-0 tasiRNA-generation loci TAS1a, TAS1b, TAS1c, TAS2, TAS3a, TAS3b, TAS3c and TAS4 are shown schematically. In each
case, position of the miRNA cleavage site is indicated by arrows; for TAS3 loci, position of the second, non-cleavable miR390-binding site is also
shown. The 21-nt tasiRNAs of both sense (+) and antisense (–) polarities produced by DCL4-mediated, in-phase processing of the dsRNA are
shown by boxes. The tasiRNAs probed in this study are in bold-lined boxes with their names indicated. The TAS1 loci-derived siR255 and siR255-
like species are in dark boxes. TAS1a- and TAS1b-derived siRNAs D1(+) species diﬀer only at 50-terminal nucleotide (U and A, respectively).
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proposed that successive ampliﬁcation of secondary
siRNAs by an RDR6-/DCL4-dependent mechanism
might function to achieve eﬃcient silencing of paralogous
genes in expanding gene families (9). The same mechanism
involving RDR6 and DCL4 appears to generate second-
ary siRNAs from silenced transgenes (22), which contri-
bute to ampliﬁcation and cell-to-cell spread of silencing
(20,23).
By analogy, RDR6-dependent production of secondary
siRNAs might contribute to anti-viral defense based on
RNA silencing (24). Indeed, RDR6 was implicated in
defense against an RNA cucumovirus (25) and in exclu-
sion of an RNA potexvirus from the shoot apical meris-
tem (26).
Cauliﬂower mosaic virus (CaMV) is a pararetrovirus
with a dsDNA genome and a polycistronic pregenomic
RNA with seven genes (27). The transactivator/viroplas-
min (TAV) is produced from a subgenomic monocistronic
CaMV RNA, and this protein activates polycistronic
translation of the remaining six proteins (28). TAV is mul-
tifunctional and equipped with the nuclear targeting and
export signals (29), as well as ssRNA- and dsRNA- and
protein-binding domains. It forms large cytoplasmic inclu-
sion bodies, within which virus particles accumulate (30).
TAV also determines symptom severity and host range
(31) and, as a transgene, causes virus-like symptoms and
late ﬂowering (32,33). Recently it was shown to act as a
suppressor of transgene silencing (34).
We and others have previously reported that four
Arabidopsis DCL proteins generate CaMV-derived
siRNAs, 21, 22 and 24 nt in length (35,36). The relative
contribution of DCL4, known to restrict RNA virus infec-
tion (37) was minor, however, and RDR6 was not
required for CaMV siRNA biogenesis (35), suggesting
that RDR6-/DCL4-dependent ampliﬁcation of viral sec-
ondary siRNAs is suppressed.
Here we report that CaMV infection interferes with
endogenous RDR6-dependent tasiRNA and secondary
siRNA pathways and demonstrate that TAV is solely
responsible for this interference. Furthermore our
work uncovers novel mechanistic features of tasiRNA-
generating pathways and suggests feedback regulation of
tasiRNA levels through activation of the tasiRNA biogen-
esis machinery.
MATERIALS AND METHODS
Arabidopsismutant and transgenic lines
Arabidopsis DCL- and RDR-deﬁcient mutant lines dcl2-5,
dcl3-1, dcl4-2, dcl23, dcl34, dcl234, rdr6-15 and rdr2-1 (all
in Col-0 background) used in this study were described
previously (35 and references therein). The CaMV TAV
transgenic Arabidopsis lines CM-2, CM-6 and D4-2 (in
Col-0 background) were constructed by Yu et al. (38).
The silenced GFP transgenic Arabidopsis line GF-
FGxGFP was described by Moissiard et al. (22)
Plant growth and virus infection
Arabidopsis wild-type, silencing-deﬁcient mutant and TAV
transgenic plants were raised from seeds in soil and
maintained in a Phytochamber (Sanyo) at 208C with
12-h light and 12-h dark. Four to ﬁve weeks post-
germination, seedlings were inoculated with CaMV using
particle bombardment as we described previously (35,39):
1 mm gold particles were coated with 1-mg plasmid DNA
of the CaMV CM1841 infectious clone pCa122 (40) and
delivered at 1100 psi. CaMV symptoms started to
develop about 3weeks post-inoculation. One month post-
inoculation, unless otherwise stated, the virus-infected
plants were harvested and used for RNA extraction.
RNA extraction and analysis
Total RNAwas extracted from 1-g plant tissue, derived from
the pools of plants grounded into ﬁne powder in liquid
nitrogen, using Trizol reagent (Invitrogen, AG, Basel, Basel
land, Switzerland) according to the manufacturer’s protocol.
About 20 or 30mg total RNAwere resuspended in 10ml load-
ing buﬀer (0.10% bromophenol blue in 100% de-ionized
formamide), heated at 958C for 2min and loaded on 15%
(or 5%) polyacrylamide denaturing gel (a 19 : 1 ratio of acryl-
amide to bis-acrylamide, 8Murea). The gel was run using the
SE 600 electrophoresis apparatus (Hoefer Inc., Holliston,
MA, USA) at 300V for 4 h and then RNAs were transferred
to a Hybond N+ membrane by electroblotting in 1 TBE
buﬀer at 10V overnight. The hybridization was performed
at 358C for 18 to 24h in UltraHyb-oligo buﬀer (Ambion,
Warrington, Cheshire, UK) using as a probe, short DNA
oligos (Table S1) end-labeled with 32P by polynucleotide
kinase (New England Biolabs/Bioconcept, Allschwil, Basel
land, Switzerland) and puriﬁed through MicroSpinTM G-25
columns (GE Healthcare, Glattbrugg, Zurich, Switzerland)
according to the manufacturers’ recommendations. The blot
was washed two times with 2SSC, 0.5%SDS for 30min at
378C. The signal was detected after exposure to a phosphor
screen using a Molecular Imager (BioRad). For repeated
hybridization, the membrane was stripped with 0.5SSC,
0.5%SDS for 30min at 808C and then with 0.1 SSC, 0.5%
SDS for 30min at 808C.
Microarray analysis
All microarray analyses were done using two replicates.
For each replicate, three to four CaMV-infected or mock-
inoculated plants and, in the case of TAV transgenic lines,
nine transgenic or wt (Col-0) seedlings grown in soil as
described above were harvested 1 month post-inoculation
and 15 days post-germination, respectively. Total RNAwas
prepared by the Trizol method as described above and
further puriﬁed using an RNeasy Plant Mini Kit (Qiagen,
AG, Hombrechtikon, Zurich, Switzerland) following the
manufacturer’s recommendations. The quality of the iso-
lated RNA was determined with a NanoDrop ND 1000
(NanoDrop Technologies) and a Bioanalyzer 2100
(Agilent Technologies). Only those samples with a
260 nm/280nm ratio between 1.8–2.1 and a 28S/18S ratio
within 1.5–2 were further processed. Total RNA samples
(2mg) were reverse-transcribed into double-stranded
cDNA, in vitro transcribed in presence of biotin-labeled
nucleotides using an IVTLabelingKit (Aﬀymetrix), puriﬁed
and quantiﬁed using BioRobot Gene Exp—cRNA Target
Prep (Qiagen). The labeled cRNA quality was determined
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using Bioanalyzer 2100. For array hybridization, biotin-
labeled cRNA samples (15mg) were fragmented randomly
to 35–200bp at 948C according to the Aﬀymetrix protocol.
Samples were hybridized to GeneChip Arabidopsis ATH1
Genome arrays for 16h at 458C. Arrays were then washed
using an Aﬀymetrix Fluidics Station 450 FS450 0004 proto-
col. AnAﬀymetrixGeneChip Scanner 3000 (Aﬀymetrix Inc.)
was used to measure the ﬂuorescent intensity emitted by the
labeled target. Raw data processing was performed using the
Aﬀymetrix AGCC software. The normalized data were
analysed using GeneSpring GX 7.3 (Agilent Technologies).
RESULTS
TAV is responsible for CaMV infection-mediated
interference with siR255 biogenesis
CaMV infection in Arabidopsis thaliana causes overaccu-
mulation of several RDR6-dependent precursors of TAS1-
derived tasiRNA siR255 (35) (Figure 2). To test whether
the CaMV TAV protein implicated in silencing suppres-
sion contributes to this eﬀect, we analyzed two Arabidopsis
transgenic lines that constitutively express TAV proteins
from the CaMV strains CM1841 and D4 (lines CM-2 and
D4-2, respectively) (38). Both lines accumulate compar-
able levels of TAV, but the CM1841 TAV plants develop
extensive chlorotic symptoms, whereas the D4 plants are
nearly symptom-less (38). Blot hybridization analysis of
total plant RNA using the siR255-speciﬁc probe showed
that both transgenic lines accumulate, in addition to the
21-nt siR255, several precursors ranging in size from 35
to 600 nt. The sizes and relative abundances of these
RNAs were very similar in both transgenic lines as well
as in control Col-0 (wt) plants infected with CaMV strain
CM1841. Moreover, CaMV infection of the TAV trans-
genic lines did not alter these patterns of RNA accumula-
tion (Figure 2). Notably, these long precursors of siR255
are also present in non-infected wt plants, albeit at very
low levels (Figure 2 and data not shown). The levels of
siR255 normalized for the U6 loading control were
reduced to 55% of the wild-type levels in CaMV-infected
plants. Of the two TAV transgenic lines, signiﬁcant reduc-
tion in siR255 levels was observed only in the D4 line (see
Figures 2 and 3). The stronger interference with siR255
biogenesis in the D4 line than in the CM1841 line was also
apparent from a higher ratio of the siR255 precursors
(a total of several RNAs ranging from 35 to 600 nt)
to the 21 nt siR255 product, compared to the CM1841 line
(Figure 2, see the imbedded table). Nonetheless, the
CM1841 line accumulated somewhat higher amounts of
the siR255 precursors.
We made a time-course analysis of the TAV eﬀect on
the siR255-generating pathway using pools of the trans-
genic and the wt plants harvested 15, 30 and 45 days post-
germination. Wt plants bolted and started to ﬂower 30–45
days post-germination, whereas the transgenic lines dis-
played slower growth and ﬂowered 1 (CM1841) or 2
(D4) months later, conﬁrming earlier observations (32).
In the CM1841 line, the siR255 precursors were equally
abundant at all three time points. In contrast, the
D4 line accumulated lower amounts of the precursors at
the two earlier time points (Figure 3). Despite the diﬀer-
ence in accumulation of the precursors, at each time point
the precursors/tasiRNA ratio was about two to three
times higher in the D4 line than in the CM1841 line
(Figure 3), conﬁrming that TAV expression in the
D4 line has a stronger negative impact on tasiRNA pro-
cessing. Interestingly, the levels of miR173 that initiates
the siR255-generating pathway (Figure 1) were increased
pronouncedly in the CM1841 line (Figure 3), thus corre-
lating with higher accumulation of the siR255 precursors.
Further analysis of infected and TAV transgenic plants
using probes speciﬁc for both strands of a presumed
tasiRNA duplex (siR255/siR255) detected longer RNAs
identical in size and relative abundance but negligible
levels of 21-nt siR255 (Figure 3). These results, and our
earlier ﬁndings for CaMV-infected wt plants (35)
(Figure 4) suggest that most larger-sized RNAs are poten-
tially double-stranded molecules. Taken together, we con-
clude that the CaMV TAV protein is solely responsible for
the CaMV-mediated interference with siR255 biogenesis.
Analysis of dsRNA precursors ofTAS1 tasiRNAs
siR255 is encoded by three TAS1 family loci TAS1a,
TAS1b and TAS1c at processing positions 30D6(+),
30D6(+) and 30D3(+), respectively, located six, six and
three 21-nt cycles downstream of the miR173 cleavage site
(6). Four additional siR255-like species are encoded by
TAS1a, TAS1b and TAS1c (Figure 1B, ﬁlled boxes). To
further characterize the long RNAs that hybridize to the
siR255- and the siR255-speciﬁc probes in CaMV-infected
plants (35), we re-probed the respective blot with P-32
labeled, 21- and 19-nt-long DNA oligonucleotides
(Table S1) complementary to the predicted TAS1a 21-nt
siRNAs 30D1(+) and 30D1(–) (Figure 1B). These probes
are expected to hybridize to the termini of presumed
dsRNAs from TAS1a and TAS1b with only 1-nt mis-
match at the end but not to those from TAS1c and
TAS2 with >4 mismatches. Such dsRNAs could be
either the hypothetical full-length products of RDR6
activity or partially processed products from an end oppo-
site to the miR173 cleavage site. We detected 21-nt TAS1a
30D1(+) species in both mock control and CaMV-infected
plants, but no 30D1(–) species (Figure 4). Both TAS1a
30D1 (+) and 30D1(–) speciﬁc probes also strongly hybrid-
ized to four of the 12 longer RNAs detectable with
siR255- and siR255-speciﬁc probes in CaMV-infected
plant samples (indicated with asterisks in Figure 4).
We also analyzed the siR255 precursors inDCL-deﬁcient
single, double and triple mutants dcl2, dcl3, dcl4, dcl23,
dcl34 and dcl234 as well as RDR-deﬁcient mutants rdr2
and rdr6, described earlier (35). To better resolve longer
precursors of tasiRNAs and identify single-stranded (ss)
TAS1 transcripts of 800–1000 nt, total RNA was sepa-
rated using 5% PAGE (Figure 5B) and low-molecular-
weight RNAs were separated using 18% PAGE
(Figure 5A). The size range of the single-stranded,
siR255-containing RNAs we detected (Figure 5B) corre-
sponded to TAS1a, 1b and 1c transcripts of 929, 838 and
989 nt in length, respectively. Strikingly, accumulation of
most TAS1-derived RNAs was perturbed in the dcl4
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mutant backgrounds relative to the wt and the other dcl
mutants (Figure 5A and B). Thus, these RNAs may
represent intermediates of DCL4-mediated processing
of the longest (full-length) dsRNA precursors of 500–
600 bp, which accumulated equally in the wt and all
the dcl mutant plants infected with CaMV (Figure 5B).
In the absence of DCL4, other DCLs appear to compen-
sate for its deﬁciency: abundant 22-nt sRNA and several
longer intermediates accumulating in dcl4 and dcl34 are
DCL2-dependent (Figure 5A and B). The 24- and 25-nt
sRNAs and two RNAs migrating at the ca. 80-nt posi-
tion are DCL3-dependent (Figure 5A). The RNA pattern
in dcl234 indicates that full-length precursors of siR255
are partially processed by DCL1 resulting in a distinct
pattern of RNA intermediates but no detectable siRNAs
(Figure 5). Finally, none of the precursors or mature
TAS1 tasiRNAs was detected in rdr6 but all were
detected in rdr2 (Figure 5A), showing that RDR6 is
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Figure 2. Accumulation of tasiRNA precursors in CaMV-infected and TAV transgenic plants. Total RNA from pools of CaMV-infected (+) or
mock-inoculated (–) wild-type plants (Col-0) and TAV transgenic lines CM1841 and D4 harvested 1 month post-inoculation were analyzed by RNA
blot hybridization (using 15% PAGE). Membranes were successively hybridized with DNA oligo probes for the tasiRNAs TAS1a/b/c siR255, TAS3a
50D7(+), the miRNAs miR173, miR390 and miR828, CaMV-derived siRNAs and the small nuclear RNA U6 (see Table S1 for probe details).
Positions of ssRNA markers are indicated. U6 signal serves as a loading control. The U6-normalized, relative levels of miRNAs are shown under the
respective scan. The U6-normalized, relative levels of the tasiRNAs and the tasiRNA precursors (a total of several RNAs ranging from 35 to
600 nt) as well as the precursor/tasiRNA ratios are shown in the table. For each miRNA and tasiRNA, its accumulation in the uninfected,
nontransgenic Arabidopsis (lane 1) was set to 1.0 (underlined). For the tasiRNA precursors, their accumulation was related to the corresponding
tasiRNA.
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required for biogenesis of these tasiRNA precursors.
Similar results were obtained for precursors and
tasiRNAs encoded by TAS2 and TAS3 loci (data not
shown).
CaMV infection and TAV expression interfere with the
pathways generating the four known tasiRNA families
We also investigated if expression of the TAS2-TAS4
families was aﬀected by CaMV infection. The single
TAS2 locus encodes siR614 and siR1940 species as the
ﬁfth cycle duplex [30D5(+) and 30D5(–)] downstream of
the miR173 site (6) (Figure 1B). In uninfected plants, the
probes speciﬁc for these tasiRNAs identiﬁed the expected
21-nt molecules. CaMV infection induced the accumula-
tion of four additional longer RNAs, whose sizes were
similar in both polarities (Figure 4). A similar pattern of
TAS2 long dsRNAs was found in the two TAV transgenic
lines, with higher levels accumulating in the CM1841 line
and a higher precursor/tasiRNA ratio in the D4 line
(Figure S1). These ﬁndings indicate that CaMV infection
and expression of TAV proteins interfere in a similar
manner with miR173-initiated, TAS1 and TAS2
pathways.
The miR390-initiated tasiRNAs are derived from three
loci of the TAS3 family (Figure 1), with TAS3a giving rise
to most of the sRNA reads (9). The TAS3a-speciﬁc
tasiRNA 50D7(+) but not its passenger strand 50D7(–)
was detected. Both sense and antisense probes detected
long precursors of TAS3a tasiRNAs in CaMV-infected,
but not mock-inoculated, wt plants and in both TAV
transgenic lines (Figures 2 and 3). Note that these precur-
sors were much less abundant in CaMV-infected plants
than in the TAV transgenic lines (Figure 2). In contrast
to TAS1 and TAS2, the TAS3a tasiRNA precursors were
more abundant in the D4 line than in the CM1841 line and
were inversely correlated in abundance with their mature
tasiRNAs (Figure 3). Nonetheless, the precursors/
tasiRNA ratio was comparable for both TAS3a and
TAS1/TAS2 in the D4 line, whereas it was higher for
TAS1/TAS2 than TAS3a in the CM1841 line (Figure 3).
This suggests that TAV expression in the D4 line exerts
strong and comparable eﬀects on both the miR173- and
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Figure 3. Diﬀerential impact of TAV proteins from CaMV strains CM1841 and D4 on TAS1 versus TAS3 tasiRNAs and their precursors. Total
RNA from pools of noninfected, wild-type (Col-0) plants and TAV transgenic lines CM1841 and D4 harvested at 15, 30 and 45 days post-
germination were analyzed by RNA blot hybridization (15% PAGE). Membranes were successively hybridized with DNA oligo probes for the
tasiRNAs TAS1a/b/c siR255, TAS1a/b/c siR255, TAS3a 50D7(+), TAS3a 50D7(–), the miRNAs miR173, miR390 and miR172, and U6 (see
Table S1 for probe details). U6 signal serves as a loading control. The U6-normalized, relative levels of the tasiRNAs and the tasiRNA precursors
(a total of several RNAs ranging from 35 to 600 nt) as well as the precursor/tasiRNA ratios are shown in the two tables. The U6-normalized,
relative levels of miRNAs are shown under the respective scan. For each miRNA and tasiRNA, its accumulation in the nontransgenic Arabidopsis at
day 15 (lane 1) was set to 1.0 (underlined). For the tasiRNA precursors, their accumulation was related to the corresponding tasiRNA.
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the miR390-initiated tasiRNA biogenesis, whereas TAV
expression in the CM1841 line has generally weaker eﬀects
on both but a more pronounced eﬀect on the miR173-
initiated tasiRNA biogenesis.
The miR828-initiated tasiRNAs derived from the single
TAS4 locus (11) are of very low abundance (9). We did
not detect any small RNA in control Col-0 plants with the
probes speciﬁc for the cloned 21 nt TAS4 siR81(–) species
or its passenger strand. In both CaMV-infected and TAV
transgenic plants, however, 24–26 nt small RNA of one
polarity was detected using the siR81(–)-speciﬁc probe
(Figures 4 and S1). This probe, but not its reverse comple-
ment (data not shown), detected long RNAs that were
equally abundant in control and CaMV-infected plants,
but overaccumulated in TAV transgenic plants. At least
one distinct long RNA appears to be CaMV TAV-speciﬁc
(indicated with asterisk in Figure S1). Thus, CaMV infec-
tion and TAV expression both interfere with the TAS4
biogenesis.
CaMV infection and TAV expression upregulate both
tasiRNA targets and components of tasiRNA biogenesis
Our ﬁnding that TAV expression dramatically increased
the accumulation of tasiRNA precursors and the ratio of
precursors to tasiRNA suggests that TAV impairs proces-
sing of RDR6-dependent dsRNA to tasiRNA by DCL4.
However, the levels of tasiRNAs themselves are not dras-
tically reduced in CaMV-infected or TAV D4 plants, and,
in some samples of the CM1841 plants, are even slightly
increased (Figures 2 and 3). This could be due to incom-
plete spatial and/or temporal overlap of viral infection
(TAV protein production) and the tasiRNA biogenesis
and activity pathways. Additionally, a feedback regulation
may partially or fully restore normal levels of tasiRNAs.
We therefore investigated if the action of tasiRNAs in
knocking down their target gene transcripts is aﬀected
and whether the genes mediating tasiRNA biogenesis are
regulated in CaMV-infected and TAV transgenic plants.
Using the ATH1 whole-genome microarray, we proﬁled
total RNA from CaMV-infected versus mock-inoculated
wt (Col-0) and tasiRNA-deﬁcient dcl234 plants (harvested
1 month post-inoculation) as well as from non-infected
transgenic versus wt (Col-0) plants harvested 15 days
post-germination. Conﬁrming the above time-course
experiment (Figure 3), the siR255 precursors were more
abundant in the CM1841 than in the D4 line samples
(Figure S2; note that, of the two independent, CM1841
TAV-expressing lines shown, CM-2 was proﬁled). Nota-
bly, the TAV transgene transcript levels were higher in the
D4 line than in the two CM1841 lines CM-2 and CM-6
(Figure S2), which is consistent with slightly higher accu-
mulation of TAV protein and its breakdown products
in this D4 line (D4-2) compared to the CM1841 lines
(38; and data not shown). The higher expression of TAV
protein in the D4 line might account for the stronger
negative impact on tasiRNA biogenesis in this line as
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Figure 4. Impact of CaMV infection on the biogenesis of tasiRNAs from diﬀerent TAS loci. Total RNA from pools of CaMV-infected (+) and
mock-inoculated wild type (Col-0) plants harvested 1 month post-inoculation were analyzed by RNA blot hybridization (15% PAGE). Membranes
were successively hybridized with DNA oligo probes for the tasiRNAs TAS1a/b/c siR255, TAS1a/b/c siR255, TAS1a/b 30D1(+), TAS1a/b 30D1(–),
TAS2 siR612, TAS2 siR1940, TAS3a 50D7(+), the miRNA miR173, the 5S rDNA repeat-associated siRNA siR1003 and U6 (see Table S1 for probe
details). U6 signal serves as a loading control. Positions of ssRNA markers are indicated. Asterisks indicate the dsRNAs hybridized to both the
internal (TAS1a/b/c siR255- and siR255-speciﬁc) and the miR173-terminal [TAS1a/b 30D1(+)- and 30D1(–)-speciﬁc] probes.
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Figure 5. Dissection of the siR255-generating pathway in CaMV-infected DCL- and RDR-deﬁcient mutants. RNA samples from CaMV-infected wild
type (Col-0), the single (dcl2-5, dcl3-1 and dcl4-2), double (dcl2 dcl3, dcl3 dcl4; 35) or triple (dcl2 dcl3 dcl4; 35) DCL-deﬁcient and the RDR2- (rdr6-
15) and the RDR6-deﬁcient (rdr2-1) mutants harvested 1 month post-inoculation were analyzed by RNA blot hybridization using 18% PAGE for
low-molecular-weight RNA (A) and 5% PAGE for total RNA (B). Membranes were successively hybridized with DNA oligo probes for TAS1a/b/c
siR255, TAS1a/b/c siR255, miR173, CaMV siRNAs and U6 (see Table S1 for probe details). U6 signal serves as a loading control. Positions of
ssRNA markers are indicated. The dsRNAs hybridized to the miR173-terminal [TAS1a/b 30D1(+)- and 30D1()-speciﬁc] probes in Figure 4 are
indicated by asterisks.
Nucleic Acids Research, 2008, Vol. 36, No. 18 5903
Downloaded from https://academic.oup.com/nar/article-abstract/36/18/5896/1074654/The-CaMV-transactivator-viroplasmin-interferes
by WWZ Bibliothek (Oeffentliche Bibliotherk der UniversitÃ¤t Basel) user
on 10 October 2017
inferred above from the dsRNA precursors/tasiRNA
ratios. However we cannot exclude that 5% diﬀerence at
the amino acid level between the two TAV proteins is
responsible for the observed eﬀects.
The microarray analysis showed that the key genes
involved in tasiRNA biogenesis including DCL4, DRB4
and AGO7 were upregulated by both CaMV infection
and TAV expression (Figure 6A, Table S2), thus support-
ing the feedback regulation hypothesis. Notably, the
D4 line exhibited a more pronounced upregulation of
these genes than the CM1841 line. Additionally, DCL1
and RDR6 were found to be modestly upregulated in the
D4 line (Figure 6A, Table S2). The transcript levels of
DRB4 and AGO7 were elevated to similar levels in both
CaMV-infected wild-type and dcl234 plants (Figure 6A,
Table S2). Interestingly, residual levels of a DCL4 tran-
script were detected in dcl234 carrying a T-DNA insertion
in the 23rd exon of the DCL4 gene and those were also
slightly elevated upon CaMV infection. Furthermore,
DCL1 was also modestly upregulated in CaMV-infected
dcl234 (Figure 6A, Table S2). Other genes presently impli-
cated in the miRNA- and tasiRNA-generating pathways,
namely AGO1, HYL1/DRB1, HEN1, SE, SGS3 and
SDE5 were not aﬀected by the CaMV challenges. Of the
silencing-related genes not implicated in the tasiRNA
pathway so far, notable CaMV-mediated upregulation
was found for AGO2, TOUSLED, NRPD1a, DDM1,
DME, HDA18, RPA2 and FAS2, whereas DRB3 was
downregulated (data not shown).
Further analysis of the microarrays revealed that several
predicted tasiRNA target genes were modestly upregu-
lated by CaMV infection (Figure 6B, Table S3). These
included (i) two ‘expressed protein’ genes targeted by
siR255 and three other tasiRNAs encoded by the
TAS1 a/b/c loci, (ii) six PPR genes targeted by single or
multiple siRNAs derived from TAS1a or TAS2 loci, (iii)
AFR4 targeted by two TAS3a siRNAs and (iv) MYB113
targeted by the TAS4 siR81(–). Thus, subsets of the tar-
gets for all the known TAS families were elevated. Most of
these were also upregulated in noninfected dcl234 plants,
consistent with the tasiRNA deﬁciency. Interestingly, the
target genes unaﬀected in the noninfected dcl234 plants
were upregulated when these plants were infected with
CaMV (Figure 6B, Table S3). Subsets of targets for
tasiRNA in all four TAS families were also elevated in
TAV transgenic lines (Figure 6B, Table S3). The target
genes aﬀected and the degree of upregulation depended
on both the TAV line and the TAS family. The CM1841
TAV expression had the most pronounced eﬀect on the
TAS4 targets with all three known targets of siR81(–)
being strongly upregulated, while its eﬀect on the TAS1
and TAS3 targets was less pronounced and on the TAS2
targets rather negligible. In contrast, the D4 TAV expres-
sion had almost no eﬀect on the TAS4 targets, whereas
most of the TAS2 targets were strongly upregulated
(Figure 6B, Table S3). Furthermore, one of the two
TAS1 targets and the TAS3 target ARF4 were more pro-
nouncedly upregulated in the D4 line than in the
CM1841 line, and the D4 line showed slightly elevated
levels of the second TAS3 target, ARF3 (Figure 6B,
Table S3).
The gene At2g39680 imbedded within TAS2
(At2g39681) in opposite orientation (7) was upregulated
upon CaMV infection and in both TAV transgenic lines
(Figure 6B, Table S3). Together with the earlier report on
its upregulation in rdr6 (41), our data suggest that
At2g39680 is a target of TAS2-derived tasiRNAs, the bio-
genesis of which is impaired by CaMV TAV.
Many targets of tasiRNAs give rise to RDR6-dependent
secondary siRNAs, likely to be involved in ampliﬁcation
of silencing (9). Thus, CaMV TAV-mediated interference
with secondary siRNA production could account for
upregulation of some of the tasiRNA targets (Table S3).
Our further inspection of the transcriptome proﬁles
revealed that both CaMV infection and TAV expression
(in one or both lines) cause upregulation of several other
Arabidopsis genes (Figure 6C, Table S4) that normally
give rise to RDR6-dependent secondary siRNAs (9).
Interestingly, many of these genes are targets of
miRNAs, like the TAS genes themselves. Notably, TAV
expression in the D4 line elevated transcript levels for most
of these genes, whereas the CM1841 line showed elevated
levels for only a few of them (Figure 6C), which is similar
to the above observations for the TAS2 targets
(Figure 6B). The vast majority of other miRNA targets,
which does not give rise to secondary siRNAs, was not
upregulated in CaMV-infected or TAV transgenic plants
(data not shown), suggesting that TAV does not interfere
with miRNA action. The notable exception is AGO1,
which represents an miRNA target gene generating sec-
ondary siRNAs that was not upregulated by TAV (data
not shown). However, expression of this gene is auto-
regulated at both post-transcriptional and transcriptional
levels by a complex ﬁne-tuning mechanism (42), which
could fully compensate for the inhibitory eﬀect of TAV.
CaMV interferes with production ofRDR6-dependent
secondary siRNAs from a silenced transgene
Our transcriptome analysis suggests that TAV interferes
with RDR6-dependent secondary siRNA pathways. To
test this hypothesis we used the Arabidopsis GFPGF-
FG transgenic line (22), which carries a green ﬂuorescent
protein (GFP) transgene driven by the CaMV 35S promo-
ter and a second transgene expressing an inverted repeat
cognate to the GF portion of the GFP coding region (GF-
FG). In this system, the 21-nt primary siRNAs produced
by DCL4-mediated processing of the GF-FG dsRNA are
thought to target the GFP transcript for cleavage and
degradation. The latter process triggers RDR6-dependent
production of secondary siRNAs from the P region of the
GFP transgene (Figure 7A). The rdr6 mutation intro-
duced into the GFPGF-FG line has been shown to
eliminate the secondary siRNAs without aﬀecting accu-
mulation of primary siRNAs or GFP silencing (22).
CaMV infection of the GFPGF-FG line did not result
in re-appearance of GFP ﬂuorescence under UV light
(data not shown), indicating that GFP silencing was not
suppressed. Consistent with the silenced GFP phenotype,
RNA blot hybridization of total plant RNA with probes
speciﬁc to the GF region showed that accumulation of
primary siRNAs of both polarities was not reduced but
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Figure 6. Response of the Arabidopsis transcriptome to CaMV infection and TAV transgene expression reveals the interference with the tasiRNA
and secondary siRNA pathways. The microarray analysis data for CaMV-infected (+) and mock-inoculated (–) Arabidopsis wt (Col-O) and the dcl2
dcl3 dcl4 triple mutant (dcl234) plants as well as for the CaMV TAV transgenic lines CM1841 and D4 are presented as the bar charts with error bars
showing standard deviation from mean value of the normalized expression levels (Tables S2–S4) of the genes upregulated in response both to CaMV
infection (in Col-0 and dcl234) and TAV expression (in CM1841 and/or D4). The data are for two samples, each representing a pool of three (or, in
the case of TAV transgenic lines, nine) plants. The statistically signiﬁcant changes are indicated by asterisks. (A) shows the genes mediating tasiRNA
biogenesis (DCL4, DRB4, AGO7, DCL1 and RDR6), (B) the genes targeted by tasiRNAs of the four TAS families (indicated in brackets) and
(C) the miRNA targets (the miRNA indicated in brackets) and other genes silenced by secondary siRNAs.
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rather slightly increased (Figure 7B). In contrast, accumu-
lation of secondary siRNAs from the P region was sub-
stantially reduced during viral infection (Figure 7B). These
results suggest that CaMV infection selectively interferes
with the biogenesis of RDR6-dependent secondary
siRNAs without any substantial eﬀect on the production
of primary siRNAs and their action in silencing GFP
expression.
DISCUSSION
TAV interferes with RDR6-/DCL4-dependent
silencing systems
We established that the CaMV TAV protein, whether
expressed from the viral genome or from a transgene,
interferes with Arabidopsis tasiRNA-generating pathways.
This interference is associated with (i) overaccumulation
of unprocessed, RDR6-dependent precursors of
tasiRNAs; (ii) increased levels of some Arabidopsis
mRNAs normally silenced by tasiRNAs of four known
TAS families; and (iii) upregulation of genes encoding
DCL4, DRB4 and AGO7, which are involved in
tasiRNA biogenesis. We also found that CaMV TAV
interferes with RDR6-dependent secondary siRNA path-
ways. The latter ﬁnding is consistent with the ability of
TAV to suppress amplicon transgene-induced silencing
(34) that depends on RDR6 (43). Furthermore, CaMV
siRNAs accumulating in infected plants are largely
RDR6- and DCL4-independent (35; Figure 5A). Taken
together, these ﬁndings suggest that TAV suppresses
silencing by preventing RDR6-/DCL4-dependent ampliﬁ-
cation of secondary siRNAs.
TAVmight act at the step of DCL4-mediated
processing of RDR6-dependent dsRNA
The available evidence suggests that TAV impairs proces-
sing of RDR6-produced dsRNA to small RNAs. In the
case of tasiRNAs, this is likely to occur in an RDR6/
DCL4 processing center believed to recruit TAS tran-
scripts targeted for cleavage by miRNAs (15). This pro-
cessing center might also generate secondary siRNAs from
some genes targeted by miRNAs or primary siRNAs (9).
Exactly how TAV inhibits processing is not known. One
possibility, which we favor, is that TAV interacts with a
protein or proteins in the processing center downstream of
RDR6 (Figure 1A). Potential targets include dsRNA-
binding proteins, such as DRB4, which is known to inter-
act with DCL4 (18), or DCL4 itself. Another possibility,
which is not mutually exclusive, is that TAV binds dsRNA
precursors and thereby inhibits their processing to
siRNAs by DCL4. While this hypothesis is consistent
with the presence of a conserved dsRNA-binding motif
in TAV (44,45), we have not been able to detect binding
of TAV to either long dsRNA and short RNA duplexes
(Shivaprasad,P.V. and Burgyan,J., unpublished data)
using a sensitive assay (46). Moreover, several lines of
evidence suggest that binding of TAV to dsRNAs per se
is not suﬃcient to block downstream processing. Thus,
we found that, in the presence of TAV, DCLs can still
eﬃciently process non-RDR-derived dsRNAs such as a
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Figure 7. CaMV infection interferes with the biogenesis of secondary siRNAs derived from the GFP transgene silenced by GF-FG dsRNA.
(A) Model for the biogenesis of the primary (GF) and the secondary (P) siRNAs derived from the GF-FG and the GFP transgenes, respectively,
in the transgenic GF-FGGFP line. The structures of the two transgenes present in this line as shown schematically, with the CaMV 35S promoter
indicated by an arrow shape. In the GF-FG transgene the inverted repeat of the GF region of the GFP coding sequence is equipped with an intron.
The Pol II transcription generates a GF-FG transcript that folds back into perfect dsRNA. The latter is processed by DCL4 (and DCL3) into
primary siRNAs (GF). These siRNAs target in trans a GFP mRNA transcribed from the GFP transgene for cleavage at multiple positions within the
GF region. The 30-product of these cleavage events retaining an intact P region is converted by RDR6 into dsRNA. The resulting dsRNA is
processed by DCL4 (and DCL3) into secondary siRNAs (P). The later step is selectively impaired by CaMV infection as inferred from the following
experiment.(B) Total RNA from CaMV-infected (+) and mock-inoculated (–) transgenic GF-FG X GFP line plants harvested 1 month post-
inoculation were analyzed by RNA blot hybridization (15% PAGE). Membranes were successively hybridized with DNA oligo probes speciﬁc for
sense and antisense siRNAs derived from the GF and P regions of the GFP coding sequence and U6 (see Table S1 for probe details). U6 signal
serves as a loading control. The U6-normalized, relative levels of siRNAs are shown under the respective scans. In each case, the siRNA accumula-
tion in the noninfected Arabidopsis was set to 1.0 (underlined).
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fold-back structure of the GF-FG transcript (Figure 7).
Similarly, RDR6-/RDR2-independent primary CaMV
siRNAs presumably processed from dsRNAs derived
from sense and antisense viral transcripts (35) were not
aﬀected by TAV overexpression in transgenic plants
(Figure 2). In future studies, it will be interesting to ana-
lyze how TAV-mediated suppression selectively impairs
processing of RDR6 products and identify which DCL4
co-factor could be responsible for selective action of
DCL4 on such dsRNA substrate.
Novel features of tasiRNA pathways
Our functional characterization of TAV uncovered
novel mechanistic and regulatory features of tasiRNA-
generating pathways. RDR6-dependent, potentially
double-stranded precursors of tasiRNAs, which overaccu-
mulated in the presence of TAV, had been previously
inferred from small RNA cloning and genetic evidence
(6) but escaped detection so far. Using dcl mutants and
RNA blot hybridization analysis, we veriﬁed that these
precursors are preferentially processed by DCL4 and iden-
tiﬁed intermediates (and/or byproducts) of this processing.
Notably, the estimated sizes of the longest (full-length)
TAS1-derived RDR6-dependent sense and antisense
RNAs fall into a range of 450–600 nt (Figure 5B), suggest-
ing that complete products of miR173-guided cleavage
of TAS1 transcripts are converted by RDR6 into
dsRNA. It was proposed that TAS1- and TAS2-derived
dsRNAs are preferentially processed from the miRNA
cleavage site terminus (6). Unexpectedly, we discovered
that some abundant, DCL4-dependent, shorter-than-full-
length TAS1 sense and antisense RNAs retain the miR173-
cleavage site terminus (Figures 4 and 5). This might be due
to processing of TAS1 dsRNA precursors from the oppo-
site side. Alternatively, at a ﬁrst round of tasiRNA biogen-
esis, certain antisense tasiRNAs produced from the
full-length dsRNAs might target the miR173-cleaved
ssTAS transcript and thus create secondary, shorter sub-
strates for RDR6. Such a two hit trigger mechanism has
been proposed for biogenesis ofTAS3-derived tasiRNAs as
well as for secondary siRNAs derived from some
Arabidopsis protein-coding genes (9,12). Our work in pro-
gress aims to precisely map the termini of the full-length
precursors of tasiRNAs and their derivatives described
here, which should lead to new insight in the biogenesis
of tasiRNAs and other RDR6-dependent siRNAs.
Our transcriptome analysis suggests that the tasiRNA
pathway is subject to negative auto-regulation. TAV
impairs processing of tasiRNAs and secondary siRNAs,
leading to increased accumulation of their target tran-
scripts. But it also upregulates genes coding for proteins
that mediate siRNA biogenesis, including DCL4, DRB4
and AGO7. Together with the rather modest eﬀects of
TAV expression on target genes, this implies that deﬁcien-
cies in the tasiRNA pathway can lead to a compensatory
activation of the key pathway components that partially
or fully restores tasiRNAs and target mRNA levels. This
hypothesis explains the diﬀerence observed for the two
distinct TAV transgenic lines, one of which (D4) accumu-
lating higher levels of target mRNAs and lower levels of
tasiRNAs than the other (CM1841), at least for TAS1,
TAS2 and TAS3 pathways (see Figures 3, 6 and S2,
respectively). This would imply more eﬃcient, feedback-
mediated restoration of the tasiRNA and mRNA target
levels in the CM1841 line than in the D4 line. Nonetheless
in both lines, as a net eﬀect of the ongoing TAV-mediated
inhibition of tasiRNA processing and the feedback upre-
gulation of tasiRNA biogenesis, the unprocessed precur-
sors of TAS1, TAS2 and TAS3 tasiRNAs overaccumulate.
The miRNA pathway genes DCL1 (11,47) and AGO1 (42)
are known to be auto-regulated. Our study supports the
view that negative feedback regulation is a general feature
of small RNA silencing pathways in plants. The mecha-
nism of feedback regulation of the tasiRNA pathway
remains to be investigated. Like in the case of miRNA-
mediated regulation of DCL1 and AGO1 (11,42, 47), the
mRNAs of DCL4, DRB4 and AGO7 may be targeted by
some tasiRNAs and/or secondary siRNAs, the biogenesis
of which is mediated by the DCL4, DRB4 and AGO7
proteins. Therefore, TAV-mediated interference with the
biogenesis of such siRNAs would elevate the levels of
the respective mRNAs. To our knowledge, no RDR6-
dependent siRNA cognate to DCL4, DRB4 or AGO7
sequences have been reported.
TAVmight suppress RNA-silencing based antiviral defense
Virus infection involves a complex interplay of host
defense mechanisms and counter-defense mechanisms of
the virus (24,48). We believe that one function of TAV is
to suppress host defense mechanisms concerned with
restricting virus spread by systemic RNA silencing.
RDR6-/DCL4-dependent mechanisms generating second-
ary siRNAs from silenced transgenes (22) and endogenous
genes (9), which are inhibited by TAV, appear to contri-
bute to the ampliﬁcation and spread of transgene silencing
(20,23). RDR6 is required for exclusion of potato virus X
from shoot apical meristem (26) and defense against
cucumber mosaic virus (25). We propose that by interfer-
ing with the ampliﬁcation of CaMV secondary siRNAs,
TAV reduces the eﬀectiveness of systemic silencing. This is
consistent with the ﬁnding that secondary viral siRNAs do
not appear to accumulate in CaMV-infected tissues: most
CaMV siRNAs are RDR6-independent (35; Figure 5A),
while DCL4, which restricts RNA-virus infection through
production of 21-nt viral siRNA (37), makes only a minor
contribution to production of CaMV siRNAs (35;
Figure 5A).
Many viruses overcome host defenses by expressing
viral proteins that suppress RNA silencing (48).
Overexpression of these suppressors in transgenic plants
often results in developmental abnormalities that result
from the interference of these proteins with the miRNA
pathway (49). Thus, some abnormalities associated with
virus infection may be ‘collateral’ eﬀects of the viruses
counter-defense to RNA silencing. Finally, the functional
redundancy of components of the miRNA pathway and
their negative auto-regulation by miRNAs might be addi-
tional layers of host defense. We assume that a similar
interplay between host and virus defenses aﬀects
tasiRNA and other secondary siRNA pathways targeted
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by TAV. While our data show that TAV does not gener-
ally aﬀect miRNA pathways, overexpression of TAV in
transgenic plants leads to various abnormalities including
delayed ﬂowering (32,33,38; and this study) that appear to
be correlated with inhibition of tasiRNA processing.
Interestingly, recent studies using the GF-FGGFP
transgenic line established that suppressor proteins of
two RNA viruses, the potyvirus HC-Pro and the carmo-
virus P38, interfere with the accumulation of secondary,
but not primary, GFP siRNAs and endogenous TAS1-
derived tasiRNAs (22). Feedback regulation in the TAS
pathway may well explain conﬂicting ﬁndings that
HC-Pro transgene expression does (22) or does not (50)
aﬀect accumulation of TAS1 tasiRNAs.
Endnote
While the manuscript of this paper was under review,
Haas et al. (51) reported that transgene expression of
TAV protein from the CaMV Cabb B-JI strain suppresses
silencing through physical interaction with DRB4 protein,
which leads to reduction of siR255 levels. They also
reported that siR255 precursors accumulate in a drb4
mutant line. Thus, their work conﬁrms our ﬁndings for
the CaMV D4 TAV line and further suggests that TAV
binding to DRB4 might interfere with DCL4-DRB4
co-operation in processing tasiRNAs, which would in
turn trigger the feedback upregulation of tasiRNA biogen-
esis components including DCL4, AGO7 and DRB4 itself
as reported here.
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